Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $291.91 | 11 | 61.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $155.00 | 1 | 32.5% |
| Education | $29.99 | 1 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $155.00 | 1 | $0 (2022) |
| Allergan, Inc. | $113.66 | 3 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $75.38 | 1 | $0 (2019) |
| ABBVIE INC. | $44.99 | 3 | $0 (2022) |
| Alkermes, Inc. | $42.90 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $31.50 | 1 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $13.47 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $171.30 | 2 | Becton, Dickinson and Company ($155.00) |
| 2021 | $60.19 | 3 | GlaxoSmithKline, LLC. ($31.50) |
| 2020 | $29.99 | 1 | Allergan, Inc. ($29.99) |
| 2019 | $75.38 | 1 | Janssen Pharmaceuticals, Inc ($75.38) |
| 2018 | $67.56 | 1 | Allergan Inc. ($67.56) |
| 2017 | $72.48 | 5 | Alkermes, Inc. ($42.90) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2022 | Becton, Dickinson and Company | FACS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $155.00 | General |
| Category: Cell Analysis | ||||||
| 03/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: VACCINES | ||||||
| 05/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2020 | Allergan, Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $75.38 | General |
| Category: Neuroscience | ||||||
| 06/12/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $67.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2017 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: CNS | ||||||
| 04/04/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CNS | ||||||
| 01/30/2017 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 01/10/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 138 | 236 | $62,693 | $17,974 |
| 2022 | 4 | 114 | 191 | $50,291 | $13,951 |
| 2021 | 3 | 141 | 278 | $70,419 | $19,973 |
| 2020 | 4 | 230 | 431 | $112,095 | $30,676 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 114 | $20,755 | $6,388 | 30.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 44 | 63 | $16,704 | $5,334 | 31.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 39 | 45 | $21,411 | $5,076 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 14 | $3,823 | $1,176 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 90 | $16,385 | $4,615 | 28.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 30 | 33 | $15,701 | $4,206 | 26.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 46 | $12,196 | $3,544 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 22 | $6,008 | $1,587 | 26.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 160 | $29,130 | $8,510 | 29.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 42 | 52 | $23,790 | $6,398 | 26.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 49 | 66 | $17,499 | $5,065 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 75 | 230 | $41,874 | $12,685 | 30.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 71 | 79 | $37,588 | $8,150 | 21.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 70 | 86 | $22,802 | $6,987 | 30.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 36 | $9,831 | $2,855 | 29.0% |
About Dr. Allison Smith, D.O
Dr. Allison Smith, D.O is a Psychiatry healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2015. The National Provider Identifier (NPI) number assigned to this provider is 1417342031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Smith, D.O has received a total of $476.90 in payments from pharmaceutical and medical device companies, with $171.30 received in 2022. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($291.91).
As a Medicare-enrolled provider, Smith has provided services to 623 Medicare beneficiaries, totaling 1,136 services with total Medicare billing of $82,574. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Joplin, MO
- Active Since 03/31/2015
- Last Updated 03/31/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1417342031
Products in Payments
- FACS (Device) $155.00
- VRAYLAR (Drug) $142.54
- SPRAVATO (Drug) $75.38
- Aristada 441 mg (Drug) $42.90
- SHINGRIX (Biological) $31.50
- VIIBRYD (Drug) $16.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Joplin
Dr. Modaser Shah, M.d, M.D
Psychiatry — Payments: $689.84
Lisset Diaz
Psychiatry — Payments: $611.77
Nauman Ashraf, M.d, M.D
Psychiatry — Payments: $349.36
Matthew Krahl
Psychiatry — Payments: $336.36
Aneel Kumar, Md, MD
Psychiatry — Payments: $327.63
Jeffrey Bradley, Md, MD
Psychiatry — Payments: $299.06